ATLANTA, March 29, 2019 /PRNewswire-PRWeb/ -- Senslytics has been selected to partner with the Shell GameChanger™ programme. The company will receive funding to apply its patented Intuition Technology to predict contamination levels of fluid samples during Formation Testing operations. Formation testing plays a critical role in the exploration and appraisal of oil and gas. These testing operations provide downhole fluid samples as well as pore pressure, mobility, permeability and anisotropy measurements, which are vital to real-time drilling safety, geosteering, hydraulic fracturing and economic analysis.
Founded in 1996, Shell GameChanger™ works with start-ups and businesses on unproven early-stage ideas with the potential to significantly impact the future of energy, providing them with seed funding, subject matter expertise, and industry connections to test the technical and commercial viability of their concept.
Senslytics sets itself apart from other data-science companies by focusing on impact correlation of situational influences and surroundings dynamics with the real time changes in Core system behavior through hypotheses iteration. Gaining Lead Time to any upcoming event is the key to avoid emergency or nonproductive operational experiences. The Intuition Technology framework is designed to do exactly that.
"Shell GameChanger™ aims to explore the possibilities of machine learning and apply these transformative technologies to solve high stake operational challenges to improve efficiency and reduce cost within the energy industry; Senslytics shows potential to solving such challenges," said Jeroen Smith who chaired the Shell GameChanger™ selection panel.
"After passing seven stages of brainstorming, challenges, testing and refinement, our team is finally ready and excited to work closely with Shell experts to embark on this complex operational challenge and demonstrate how our Forewarning application software built on Intuition Technology, can add significant value to formation testing," said Senslytics President, Dr. Rabi Chakraborty.
SOURCE Senslytics
Share this article